What if we could determine a baby’s risk of cancer or Alzheimer’s disease later in life, by studying their DNA? And what if we could print at home the drug to treat a specific disorder? It might look a bit like science fiction right now, but it’s what personalised medicine could achieve in the coming years.
The new era of targeted treatment could lead to finer diagnoses, tailored medical prescriptions, custom-made disease monitoring and reduced care costs. What can hospitals start doing today to bring it closer to reality? How can research centres and universities help?
A great deal of personalised medicine’s success depends on our ability to retrieve and share patient data, in particular from medical monitoring devices but also satisfaction surveys. Two words to describe this approach: Patient outcomes.
Using these records, organisations such as the WHO and the OECD, in cooperation with the European Commission, develop comparisons across countries on who gets the best value for money, and who the best outcomes.
Now, back to reality in 2018: how to collect this data, compare (real) performances across health systems and take a step forward toward personalised medicine – and enter the next era of health care systems?
But the accompanying challenge for European member states with universal healthcare coverage is how to find value with limited financial resources; how to make public health systems sustainable.
So, delving deeper into the future of health, value-based healthcare is a challenging question. If health systems became “value-based”, care providers would be paid based on patient health outcomes. This means that hospitals and physicians are rewarded for helping patients improve their health, reduce the effects of chronic diseases and help patients live healthier lives.
Personalised medicine and value-based healthcare are closely connected concerns and the use of patient outcomes is crucial to the development of the value-based approach: In order to know whether a drug is effective, what better way to monitor patients’ recovery than by collecting their opinions?
Besides, the value-based approach would give incentives to companies to develop personalised medicine solutions such as tailored drugs, diet and exercise outcomes monitoring and telemedicine services - improving disease prevention and earning lots of healthy years for the whole population.
Barcelona is among the trailblazers in the healthcare revolution, being home to the third most powerful supercomputer in Europe: the MareNostrum 4, hosted by Barcelona Supercomputing Centre. Machines like the MareNostrum 4 are essential to achieve personalised medicine as they are capable of analysing large amounts of data, such as medical records, imagery, genomic and rare diseases traces – helping biomedicine advance to the next level.
This event will be a unique opportunity for a high-level debate on value-based health care, personalised medicine and patient outcomes in Barcelona, which are still matters under discussion in Spain.
Science|Business will organise a conference on 19 September 2018 at the Hospital St. Joan de Déu, Barcelona, to elevate the issue of value-based healthcare.
September 18th (20:30-22:30) : VIP dinner for Healthy Measures Steering Committee members and speakers, by invitation only.
September 19th (9:30-17:30) : Open Conference, Hospital St. Joan de Déu, Auditorium.
Hosted by the Hospital St. Joan de Déu, Barcelona / Supported by the Barcelona Supercomputing Centre
10:00 - Welcome words
10:20 - Opening addresses
11:20 - Value-based healthcare - linking outcomes to value?
How to drive value-based healthcare for pharma, hospitals and insurance - Panel discussion on the focus on outcomes to measure value in healthcare .
13:00 - Patient outcomes at the intersection between personalised medicine and value-based healthcare?
A substantial change for many physicians and other healthcare professionals – to focus on outcomes to measure value and by making better use of health data to improve the health of the EU citizens and reduce healthcare costs.
13:45 - Lunch
15:00 - Personalised medicine, will broad access to patient data help achieve better outcomes?
Patient data as fuel for personalised medicine - panel discussion on the benefits to patients, entrepreneurs, governments and society; use of patient data for prescribing the right drugs for a patient, at the right doses, tailored for their specific genetic make-up for better health care while reducing costs.
16:00 - Healthcare Financing based on Value
A shift from fee-for-service to value-based care –Building the new Health Business Model on Patient Outcomes Measurements - In search of value in models of publicly-financed healthcare delivery.
16:45 - Conclusions: Paving the way towards outcomes-based healthcare systems
Moderator: Monica Dietl, Senior Adviser, Science|Business
17:30 – Visit of the Supercomputing Center – Mare Nostrum, for speakers only.
Venue: Auditorium - Hospital Sant Joan de Déu Barcelona, Passeig de Sant Joan de Déu, 2, 08950 Esplugues de Llobregat, Barcelona, Spain
For more information regarding this event, please contact Lysiane Pons at firstname.lastname@example.org